Research output per year
Research output per year
Personal profile
Qualifications
2024: Doctor of Philosophy (PhD), The University of Manchester
2021: Registration with General Pharmaceutical Council
2020: Provisional registration with General Pharmaceutical Council
2019: Master of Pharmacy (MPharm), The University of Manchester
Research interests
- Mental health patient safety - primary and secondary care
- Psychotropic medication use and safety
- Appropriate prescribing and monitoring of psychotropics
- Medication errors (prescribing, monitoring, dispensing and administration)
- Adverse drug events
- Epidemiology and aetiology of medication safety issues for patients with mental illness
Memberships of committees and professional bodies
Registered General Pharmaceutical Council (GPhC)
Member Royal Pharmaceutical Society (RPS)
Associate Fellow of the Higher Education Academy (AFHEA)
Pharmacist's Defence Association (PDA)
Associate Member College of Mental Health Pharmacy (CMHP)
Member British Association for Psychopharmacology (BAP)
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Doctor of Philosophy, Understanding the medication safety issues affecting patients with mental illness in primary care
12 Apr 2021 → 30 May 2024
Award Date: 30 May 2024
Master of Pharmacy, MPharm
21 Sept 2015 → 25 Jun 2019
Award Date: 25 Jun 2019
Areas of expertise
- RM Therapeutics. Pharmacology
- RS Pharmacy and materia medica
Fingerprint
Dive into the research topics where Matthew Ayre is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Towards understanding and improving medication safety for patients with mental illness in primary care: a multimethod study
Ayre, M. (Lead), Lewis, P., Phipps, D., Morgan, K. & Keers, R., 1 Jun 2024, In: Health Expectations. 27, 3, e14095.Research output: Contribution to journal › Article › peer-review
Open Access -
unDerstandIng the cauSes of mediCation errOrs and adVerse drug evEnts for patients with mental illness in community caRe (DISCOVER): a qualitative study
Ayre, M., Lewis, P., Phipps, D. & Keers, R., 7 Dec 2023, In: Frontiers in Psychiatry. 14, 1241445.Research output: Contribution to journal › Article › peer-review
Open Access -
Understanding the medication safety challenges for patients with mental illness in primary care: a scoping review
Ayre, M., Lewis, P. & Keers, R., 12 Jun 2023, In: BMC Psychiatry. 23, 1, 417.Research output: Contribution to journal › Article › peer-review
Open Access -
Understanding the medication safety issues for patients with mental illness in primary care: a scoping review
Ayre, M., Lewis, P. & Keers, R., 9 Aug 2022, Society for Academic Primary Care. 1 ed. Oxford, Vol. 1. p. 90-91 223 p.Research output: Chapter in Book/Report/Conference proceeding › Conference contribution › peer-review
Open Access
Thesis
-
Understanding the medication safety issues affecting patients with mental illness in primary care
Ayre, M. (Author), Keers, R. (Supervisor), Lewis, P. (Supervisor) & Phipps, D. (Supervisor), 1 Aug 2024Student thesis: Phd
File